feed,title,long_url,short_url
Benzinga,Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform,https://benzinga.com/analyst-ratings/analyst-color/24/03/37829667/analyst-bullish-on-gene-therapy-focused-voyager-therapeutics-sees-best-in-class-pot,https://da.gd/8GR5dA
Benzinga,"New CEO, Bottoming Cycle, And Spin-Off Fuel Optimism For 3M, Analyst Upgrades Stock",https://benzinga.com/analyst-ratings/analyst-color/24/03/37829625/new-ceo-bottoming-cycle-and-spin-off-fuel-optimism-for-3m-analyst-upgrades-stock,https://da.gd/bz7XHP
Benzinga,Trade Desk's Options: A Look at What the Big Money is Thinking,https://benzinga.com/insights/options/24/03/37829726/trade-desks-options-a-look-at-what-the-big-money-is-thinking,https://da.gd/gJrX49
Benzinga,Arch Resources's Options: A Look at What the Big Money is Thinking,https://benzinga.com/insights/options/24/03/37829669/arch-resourcess-options-a-look-at-what-the-big-money-is-thinking,https://da.gd/cxR9V
